Trials / Completed
CompletedNCT02190786
Phase II Exploratory Clinical Study of KUX-1151
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy, safety and pharmacokinetics of multiple oral administration of KUX-1151 in patients with hyperuricemia including gout.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KUX-1151 |
Timeline
- Primary completion
- 2015-03-01
- First posted
- 2014-07-15
- Last updated
- 2015-10-19
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02190786. Inclusion in this directory is not an endorsement.